AMEX · Biotechnology

PHGE (PHGE) Stock

$1.85 +14.20% AMEX: PHGE Healthcare

Valuation

MetricValue
Price$1.85
Market Cap$1.88M
P/E Ratio-0.01
P/B Ratio0.12
P/S Ratio4.00
EPS (TTM)$-12.58
52-Week High$12.29
52-Week Low$0.12
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-947.73%
ROA-161.13%
ROCE-124.63%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.31
Current Ratio1.00

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-35.0M$-27.0M$-28.0M$-39.0M$-33.0M
Net Profit$-36.0M$-28.0M$-26.0M$-18.0M$-36.0M
EPS$-264.67$-180.31$-96.90$-27.93$-22.19
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$78.0M$46.0M$25.0M$43.0M$70.0M
Total Liabilities$30.0M$24.0M$22.0M$19.0M$72.0M
Cash$62.0M$31.0M$15.0M$18.0M$5.0M
Borrowings$20.0M$19.0M$15.0M$10.0M$1.0M

Latest News

BiomX: Zorronet Completes Transition to New Advanced Data Center Supporting Business Expansion and Enhanced AI Capabilities GlobeNewswire · Jul 10, 2026 BiomX Signs Non-Binding Letter of Intent to Acquire Control of Revenue-Generating Security Infrastructure and Systems Integration Company, Expanding Its Security Platform with Critical Infrastructure and Secure-Site Integration Capabilities GlobeNewswire · Jul 8, 2026 BiomX: Subsidiary Zorronet Commences Installation and Operation of AI-Powered Detection Systems Under Israel Railways Agreement GlobeNewswire · Jul 6, 2026 BiomX: Next-Gen Counter Drone Solutions will be Showcased by DFSL at ISC 2026 GlobeNewswire · Jun 24, 2026 BiomX Provides Update on Defense Technology Portfolio and Growth Strategy GlobeNewswire · Jun 18, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-28.0M$-29.0M$-21.0M$-37.0M$-26.0M
Investing Cash Flow$12.0M$-2.0M$2.0M$1.0M$0
Financing Cash Flow$0$0$0$28.0M$0
Net Cash Flow$26.0M$-31.0M$-16.0M$2.0M$-13.0M
Free Cash Flow$-31.0M$-29.0M$-21.0M$-37.0M$-26.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.18
FCF Yield-1366.02%
Quick Ratio0.24
Interest Coverage-27.30
Return 1Y-97.23%
Return 3Y-99.72%
Return 5Y-99.98%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ADAPAdaptimmune Therapeutics plc $0.05 -3.00% -0.16 $75.16M 0.00%
BRTXBioRestorative Therapies, Inc. $1.59 -9.14% -0.10 $2.20M 0.00%
DWTXDogwood Therapeutics, Inc. $1.30 -5.11% -0.18 $43.72M 0.00%
EDSAEdesa Biotech, Inc. $2.85 -3.23% -2.28 $27.41M 0.00%
ERNAErnexa Therapeutics Inc. $2.21 +0.00% -0.15 $3.61M 0.00%

About PHGE

PHGE is led by CEO Marina Wolfson, employs 20 people, headquartered in US, publicly traded since 2019.

PHGE stock trades at $1.85 with a market capitalization of $1.88M. The stock is valued at a price-to-earnings (P/E) ratio of -0.01, price-to-book of 0.12, price-to-sales of 4.00. Over the past 52 weeks the stock has ranged between $0.12 and $12.29, and currently trades 85.0% below its 52-week high.

On profitability, PHGE generates a return on equity (ROE) of -947.73%, return on capital employed of -124.63%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Eli Lilly and Company $1166.51 -1.36% JNJ Johnson & Johnson $248.61 -5.73% ABBV AbbVie Inc. $274.31 -2.42% MRK Merck & Company, Inc. Common Stock (new) $141.98 -2.39% UNH UnitedHealth Group Incorporated Common Stock (DE) $377.76 -0.20% NVS Novartis AG $142.41 -0.99% TMO Thermo Fisher Scientific Inc $663.04 +0.12% AZN AstraZeneca PLC $155.82 -1.59% AMGN Amgen Inc. $412.84 -1.13% GILD Gilead Sciences, Inc. $147.92 -1.67% ABT Abbott Laboratories $102.67 +0.83% NVO Novo Nordisk A/S $38.06 -1.35%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides